Edenred (ENXTPA:EDEN) Names A New COO, Is The Stock Fully Priced?
Why Edenred’s new COO for Benefits & Engagement matters for shareholders
Edenred (ENXTPA:EDEN) has drawn fresh attention after naming Fabrizio Ruggiero as Chief Operating Officer for Benefits & Engagement, with a brief that ties directly into its Amplify2528 plan.
The move puts Edenred’s largest revenue segment, Benefits & Engagement, under new leadership. Investors watching client acquisition, Average Revenue per User and product development now have a new executive figure to factor into their assessment.
Against this backdrop, Edenred’s share price has shown strong recent momentum, with a 39.17% 3 month share price return and 62.10% year to date, while the 36.16% 1 year total shareholder return contrasts with weaker 3 and 5 year total shareholder returns that remain in decline.
Compare Edenred’s current momentum and executive shake up with a hand picked set of payment and finance peers using the 257 high quality undervalued stocks to explore potential alternatives for your watchlist.
Edenred now trades slightly above the average analyst target, yet sits at a large discount to one intrinsic value estimate. Is the market rightly cautious after weak multi year returns, or mispricing the Benefits & Engagement story?
Most Popular Narrative: 1.9% Overvalued
The most followed valuation narrative puts Edenred’s fair value at €29.89, just below the last close at €30.45. This frames a relatively tight valuation gap.
Robust expansion in Latin America and Asia through organic growth and targeted acquisitions (e.g., Spirii in Denmark, RB in Brazil, and IP Plus in Italy) is diversifying revenue streams, reducing exposure to sluggish European markets, and supporting top-line growth even in uncertain environments.
See what kind of revenue profile and profit margins this narrative is based on. The assumptions link earnings growth, valuation multiple and discount rate in a way that might surprise you.
Result: Fair Value of €29.89 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Edenred’s story still carries execution risk. Slower growth in mature European markets or rising competition from fintechs could quickly challenge this view that the shares are close to fair value.
Find out about the key risks to this Edenred narrative.
Another View on Edenred’s valuation
The analyst narrative frames Edenred as only 1.9% overvalued at €29.89. Yet our DCF model suggests a very different picture, with Edenred trading at a 69.6% discount to an estimated future cash flow value of €100.01. Which set of assumptions do you find more convincing?
Look into how the SWS DCF model arrives at its fair value.
Next Steps
If this mix of enthusiasm and caution around Edenred leaves you undecided, act quickly and review both sides of the story through the 2 key rewards and 4 important warning signs.
Looking for more investment ideas beyond Edenred?
If you want a fuller picture than Edenred alone can offer, use the Simply Wall St Screener now or risk missing other compelling opportunities lining up today.
- Spot potential value opportunities early by scanning the 257 high quality undervalued stocks that pair strong fundamentals with compressed valuations.
- Strengthen your downside protection by focusing on companies in the 306 resilient stocks with low risk scores that score well on resilience and financial risk checks.
- Get ahead of the crowd by reviewing the 619 high quality undiscovered gems that combine solid fundamentals with relatively low current market attention.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com